Skip to main content

2012 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
12/21/12Bard to Present at J.P. Morgan Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Dec. 21, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 8, 2013. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 4:30 PM Pacific Standard Time (7:30 PM Eastern Standard Time). A live audio webcast of Bard's prese... 
Printer Friendly Version
12/12/12Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Dec. 12, 2012-- The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share. The dividend is payable on February 1, 2013 to shareholders of record at the close of business on January 22, 2013. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hi... 
Printer Friendly Version
10/23/12Bard Announces Third Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 23, 2012-- C. R. Bard, Inc. (NYSE: BCR) today reported 2012 third quarter financial results. Third quarter 2012 net sales were $722.9 million, an increase of 1 percent over the prior-year period on a reported basis. Excluding the impact of foreign exchange, third quarter 2012 net sales increased 3 percent over the prior-year period. For the third quarter 2012, net sales in the U.S. were $483.4 million,... 
Printer Friendly Version
10/23/12Bard Acquires Neomend, Inc.
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 23, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that it has entered into a definitive agreement to acquire privately-held Neomend, Inc., a leading developer and supplier of sprayable surgical sealants and anti-adhesion products for a purchase price of $140 million paid at closing and future contingent payments up to an additional $25 million based on specific revenue-based milestones through 2016. The ... 
Printer Friendly Version
10/10/12Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 10, 2012-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share. The dividend is payable on November 2, 2012 to shareholders of record at the close of business on October 22, 2012. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hi... 
Printer Friendly Version
10/01/12Bard to Host Earnings Conference Call on October 23, 2012
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 1, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Tuesday, October 23, 2012 at 5:00 PM EDT, to discuss the company's third quarter 2012 operating results, and to provide financial guidance for the fourth quarter of 2012. Bard is scheduled to issue an earnings press release after the market closes on October 23, 2012. A live audio webcast of Bard's investor conference will be accessible to all investors through... 
Printer Friendly Version
07/25/12Bard Announces Second Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 25, 2012-- C. R. Bard, Inc. (NYSE: BCR) today reported 2012 second quarter financial results. Second quarter 2012 net sales were $742.6 million, an increase of 2 percent over the prior-year period on a reported basis. Excluding the impact of foreign exchange, second quarter 2012 net sales increased 4 percent over the prior-year period. For the second quarter 2012, net sales in the U.S. were $490.0 million, an increase of 2 percent over the prior-ye... 
Printer Friendly Version
07/25/12Bard Announces Enrollment Completion of First Ever IDE-Approved Drug-Coated Balloon Clinical Trial and Initiation of Large Continuation Registry Study
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 25, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that its Lutonix technology center completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial (http://www.levant2.com). The purpose of this pivotal IDE trial is to compare the safety and efficacy of the Lutonix® Drug Coated PTA Dilatation Catheter (DCB) to a standard angioplasty balloon for the treatment of peripheral arterial disease. LEVANT 2 was the first drug-c... 
Printer Friendly Version
07/18/12Bard to Host Earnings Conference Call on July 25, 2012
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 18, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Wednesday, July 25, 2012 at 5:00 PM EDT, to discuss the company's second quarter 2012 operating results, and to provide financial guidance for the third quarter of 2012. Bard is scheduled to issue an earnings press release after the market closes on July 25, 2012. A live audio webcast of Bard's investor conference will be accessible to all investors through Ba... 
Printer Friendly Version
06/13/12Bard Announces $500 Million Share Repurchase Authorization
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 13, 2012-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today authorized the repurchase of up to $500 million of the company's common stock. This is in addition to approximately $88 million remaining under the June 2010 authorization. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. C. R. Bard, Inc. (http://www.crbard.com/), headquartered in Murray Hill, NJ, is a leading multinat... 
Printer Friendly Version
06/13/12Bard Increases Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 13, 2012-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today increased the quarterly dividend on Bard's common stock by 5 percent, to 20 cents per share. The dividend is payable on August 3, 2012 to shareholders of record at the close of business on July 23, 2012. C. R. Bard, Inc. (http://www.crbard.com/), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical ... 
Printer Friendly Version
04/30/12Bard Names Christopher S. Holland Senior Vice President and Chief Financial Officer
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 30, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that Christopher S. Holland has been named Senior Vice President and Chief Financial Officer, effective May 21, 2012. In this role, Mr. Holland will report directly to Timothy M. Ring, Chairman and Chief Executive Officer. Mr. Holland, age 45, has most recently served as Senior Vice President, Finance and Treasurer of ARAMARK Corporation, as Senior Vice President and Treasurer from 2006 through 201... 
Printer Friendly Version
04/24/12Bard Announces First Quarter Results
Diluted EPS of $1.60, $1.61 on Adjusted Basis MURRAY HILL, N.J., Apr 24, 2012 (BUSINESS WIRE) --C. R. Bard, Inc. (NYSE: BCR) today reported 2012 first quarter financial results. First quarter 2012 net sales were $730.0 million, an increase of 4 percent over the prior-year period on a reported basis. Excluding the impact of foreign exchange, first quarter 2012 net sales increased 5 percent over the prior-year period. For the first quarter 2012, net sales in the U.S. were $496.2 million, an ... 
Printer Friendly Version
04/18/12Bard Declares Quarterly Dividend
MURRAY HILL, N.J., Apr 18, 2012 (BUSINESS WIRE) --The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 19 cents per share on Bard's common stock. The current indicated annual dividend rate is 76 cents per share. The dividend is payable on May 11, 2012 to shareholders of record at the close of business on April 30, 2012. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and ma... 
Printer Friendly Version
04/17/12Bard to Host Earnings Conference Call on April 24, 2012
MURRAY HILL, N.J., Apr 17, 2012 (BUSINESS WIRE) --C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Tuesday, April 24, 2012 at 5:00 PM EDT, to discuss the company's first quarter 2012 operating results, and to provide financial guidance for the second quarter of 2012. Bard is scheduled to issue an earnings press release after the market closes on April 24, 2012. A live audio webcast of Bard's investor conference will be accessible to all investors through Bard... 
Printer Friendly Version
01/31/12Bard Announces Fourth Quarter Results
Revenue up 5 Percent, Diluted EPS of $1.30, $1.70 on Adjusted Basis MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 31, 2012-- C. R. Bard, Inc. (NYSE: BCR) today reported 2011 fourth quarter financial results. Fourth quarter 2011 net sales were $751.9 million, an increase of 5 percent over the prior-year period, on both an as-reported and constant currency basis. For the fourth quarter 2011, net sales in the U.S. were $502.5 million and net sales outside the U.S. were $249.4 million, an increa... 
Printer Friendly Version
01/24/12Bard to Host Earnings Conference Call on January 31, 2012
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 24, 2012-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Tuesday, January 31, 2012 at 5:00 PM EST, to discuss the company’s operating results for the fourth quarter and full year 2011, and to provide financial guidance for the first quarter of 2012. Bard is scheduled to issue an earnings press release after the market closes on January 31, 2012. A live audio webcast of Bard's investor conference will be accessible t... 
Printer Friendly Version
Print Page Print Page | E-mail Page E-mail Page